Literature DB >> 6439866

HLA antigens and toxicity to gold and penicillamine in rheumatoid arthritis.

O Scherak, J S Smolen, W R Mayr, F Mayrhofer, G Kolarz, N J Thumb.   

Abstract

One hundred sixty-eight patients with rheumatoid arthritis treated with chloroquine (n = 87), gold salts (n = 133) and/or penicillamine (n = 77) were investigated for possible associations between HLA antigens and toxic reactions. Patients with 2 or more side effects to gold and/or penicillamine had a significantly increased frequency of antigens HLA-B8 and DR3 compared to patients with one or without adverse reactions. Proteinuria to gold or penicillamine was significantly associated with HLA-B8 (relative risk [RR] 4.2) and DR3 (RR 14.0) whereas nonnephrologic side effects to gold or penicillamine were associated with B7 and DR2 (RR 3.5 and 2.8). Patients with skin reactions to gold had a significantly greater frequency of HLA-B7. We found no correlation between chloroquine side effects and any HLA antigen. The results suggest a genetic predisposition to toxic reactions to gold or penicillamine based on an immunologic dysregulation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6439866

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  8 in total

Review 1.  Idiosyncratic drug reactions: a mechanistic evaluation of risk factors.

Authors:  B K Park; M Pirmohamed; N R Kitteringham
Journal:  Br J Clin Pharmacol       Date:  1992-11       Impact factor: 4.335

2.  Association of HLA-B35 with mucocutaneous lesions in Israeli patients with rheumatoid arthritis receiving gold treatment.

Authors:  M Tishler; D Caspi; E Gazit; M Yaron
Journal:  Ann Rheum Dis       Date:  1988-03       Impact factor: 19.103

Review 3.  Adverse reactions with oral and parenteral gold preparations.

Authors:  E C Tozman; N L Gottlieb
Journal:  Med Toxicol       Date:  1987 May-Jun

4.  Gold induced nephropathy in rheumatoid arthritis and HLA class II genes.

Authors:  L I Sakkas; I C Chikanza; R W Vaughan; K I Welsh; G S Panayi
Journal:  Ann Rheum Dis       Date:  1993-04       Impact factor: 19.103

5.  A T-cell response to the anti-arthritic drug penicillamine in the mouse: requirements for generation of the drug-derived antigen.

Authors:  C A O'Donnell; J W Coleman
Journal:  Immunology       Date:  1992-08       Impact factor: 7.397

Review 6.  Penicillamine in rheumatoid arthritis. A problem of toxicity.

Authors:  H G Taylor; A Samanta
Journal:  Drug Saf       Date:  1992 Jan-Feb       Impact factor: 5.606

7.  Association between gold induced skin rash and remission in patients with rheumatoid arthritis.

Authors:  D Caspi; M Tishler; M Yaron
Journal:  Ann Rheum Dis       Date:  1989-09       Impact factor: 19.103

8.  A case of polymyositis in a patient with primary biliary cirrhosis treated with D-penicillamine.

Authors:  J H Ahn; T H Kim; K R Peck; Y W Song
Journal:  Korean J Intern Med       Date:  1993-01       Impact factor: 2.884

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.